A prognostic model for the development of post-laser hyperpigmentatio
Not Applicable
Active, not recruiting
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0008763
- Lead Sponsor
- Kyung Hee University Hospital at Gangdong
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Aged over or equal to 19 years
2. have at least one solar lentigo
Exclusion Criteria
if they were treated for the solar lentigo; had undergone any energy-based procedures involving solar lentigo lesions in the previous 12 months; were immunosuppressed or treated with immunosuppressive agents in the previous 4 weeks; had used topical steroid, retinoid, hydroquinone, or any depigmenting agents in the previous 12 weeks; had a history of keloid; had diabetes mellitus or any condition that could affect would healing; had infection or other skin disease in the solar lentigo lesion; or had photosensitivity or taking photosensitive medications.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of postinflammatory hyperpigmentation
- Secondary Outcome Measures
Name Time Method Average melanin